Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities.

[1]  Valentin Fuster,et al.  Imaging of atherosclerosis: magnetic resonance imaging. , 2011, European heart journal.

[2]  E. Guallar,et al.  Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART) , 2011, Lipids in Health and Disease.

[3]  E. Sijbrands,et al.  CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemia , 2011, Heart.

[4]  C. Rochitte,et al.  Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia. , 2010, Atherosclerosis.

[5]  R. Virmani,et al.  Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Kavita Sharma,et al.  Clinical and research applications of carotid intima-media thickness. , 2009, The American journal of cardiology.

[7]  J. Witteman,et al.  Efficacy of statins in familial hypercholesterolaemia: a long term cohort study , 2008, BMJ : British Medical Journal.

[8]  S. Humphries,et al.  Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study , 2008, European heart journal.

[9]  R. Alonso,et al.  Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors. , 2008, Atherosclerosis.

[10]  S. Schmitz,et al.  Quantitative 3T MR imaging of the descending thoracic aorta: patients with familial hypercholesterolemia have an increased aortic plaque burden despite long-term lipid-lowering therapy. , 2008, Journal of vascular and interventional radiology : JVIR.

[11]  C. Rochitte,et al.  No correlation and low agreement of imaging and inflammatory atherosclerosis' markers in familial hypercholesterolemia. , 2008, Atherosclerosis.

[12]  S. Humphries,et al.  Familial hypercholesterolaemia: summary of NICE guidance , 2008, BMJ : British Medical Journal.

[13]  T. Autti,et al.  Aorta of young and middle-aged heterozygous familial hypercholesterolemia patients shows no functional or morphological impairment assessed by MRI , 2008, Vascular health and risk management.

[14]  Zahi A Fayad,et al.  Aortic Plaque Imaging and Monitoring Atherosclerotic Plaque Interventions , 2007, Topics in magnetic resonance imaging : TMRI.

[15]  Z. Fayad,et al.  Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[16]  Z. Fayad,et al.  In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography. , 2004, American heart journal.

[17]  F. Civeira,et al.  Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. , 2004, Atherosclerosis.

[18]  René M. Botnar,et al.  Age and Sex Distribution of Subclinical Aortic Atherosclerosis: A Magnetic Resonance Imaging Examination of the Framingham Heart Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[19]  V. Fuster,et al.  Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. , 1994, Journal of the American College of Cardiology.

[20]  Mark Woodward,et al.  Journal of Cardiovascular Magnetic Resonance Open Access Cardiovascular Magnetic Resonance Parameters of Atherosclerotic Plaque Burden Improve Discrimination of Prior Major Adverse Cardiovascular Events Background , 2022 .